01.06.2001 | original article
Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias
Erschienen in: Annals of Hematology | Ausgabe 6/2001
Einloggen, um Zugang zu erhalten